Table 2.
CDI vs. HbA1c | CDI vs. MBG | CDI vs. CRP | |||||||
---|---|---|---|---|---|---|---|---|---|
Controlling for | n | r | p-value* | n | r | p-value* | n | r | p-value* |
Unadjusted | 84 | 0.40 | 0.0002 | 84 | 0.35 | 0.0011 | 81 | 0.16 | 0.1454 |
Age | 84 | 0.41 | 0.0001 | 84 | 0.34 | 0.0012 | 81 | 0.18 | 0.1043 |
Gender | 84 | 0.40 | 0.0001 | 84 | 0.36 | 0.0007 | 81 | 0.14 | 0.1871 |
Race | 84 | 0.11 | 0.3016 | 84 | 0.15 | 0.1488 | 81 | 0.33 | 0.0021 |
BMI-z | 83 | 0.38 | 0.0004 | 83 | 0.34 | 0.0014 | 80 | 0.15 | 0.1730 |
BMI, body mass index; CDI, concentrated disadvantage index; CRP, C-reactive protein; HbA1c, hemoglobin A1c; MBG, mean blood glucose.
Statistical associations were assessed by Spearman’s correlation